Phase III Trial Confirms ORR in Previously Treated Patients who Received Opdivo October 20, 2016Vol.39 No.09
Yervoy Improved OS in Fully Resected Stage III Patients from Phase III Study October 20, 2016Vol.39 No.09
Phase III Tecentriq Study Shows Better Survival vs. Chemo Regardless of PD-L1 Status October 20, 2016Vol.39 No.09
In Brief Boris Lushniak named dean of the University of Maryland School of Public Health October 14, 2016Vol.42 No.38
In Brief Marc Benioff and wife Lynne give $20 million toward construction of the Lawrence J. Ellison Institute for Transformative Medicine of University of Southern California October 14, 2016Vol.42 No.38
Conversation with The Cancer Letter Davidson Moves to Seattle Cancer Consortium October 14, 2016Vol.42 No.38By Paul Goldberg
In Brief Merck KGaA announces the recipients of the 2016 Grant for Oncology Innovation October 14, 2016Vol.42 No.38
